Currently in shortage
Novartis manufacturing site in Switzerland experiencing capacity constraints. Critical oncology medicine — do NOT stop without haematologist guidance.
Expected resolution: 30 September 2025
Alternatives:
- Generic imatinib 400 mg — limited brands available
imatinib
Glivec
400 mg · tablet · Oncology
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $31.60 |
PBS Information
- Item code
- ONC001
- Drug name
- imatinib
- Brand name
- Glivec
- Manufacturer
- Novartis
- Formulation
- tablet
- Strength
- 400 mg
- Max quantity
- 30 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Oncology
TGA Reference: TGA-MSI-2025-033 · Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.